Current Liabilities
Other accrued liabilities
Medtronic Other accrued liabilities increased by 11.1% to $3.50B in Q4 2025 compared to the prior quarter. Year-over-year, this metric declined by 0.6%, from $3.53B to $3.50B. Over 4 years (FY 2021 to FY 2025), Other accrued liabilities shows relatively stable performance with a 1.5% CAGR.
Analysis
StatementBalance Sheet Statement
SectionCurrent Liabilities
CategoryLiquidity
SignalContext dependent
VolatilityModerate
First reportedQ4 2015
Last reportedQ3 2026Feb 24, 2026
How to read this metric
Significant fluctuations may indicate changes in business model, such as shifts in deferred revenue recognition or changes in short-term regulatory obligations.
Detailed definition
This category includes miscellaneous short-term obligations that are not classified under accounts payable or accrued li...
Peer comparison
Commonly used as a catch-all for short-term liabilities; varies by industry and business model.
Metric ID:
current_liabilities_other_liabilities_currentHistorical Data
20 periods
| Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | Q2 '26 | Q3 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $3.48B | $3.65B | $3.47B | $3.54B | $3.55B | $3.82B | $4.03B | $3.63B | $3.58B | $3.58B | $3.30B | $3.49B | $3.58B | $3.60B | $3.26B | $3.53B | $3.68B | $3.60B | $3.15B | $3.50B |
| QoQ Change | — | +5.1% | -5.0% | +2.1% | +0.3% | +7.5% | +5.6% | -9.9% | -1.3% | +0.0% | -7.9% | +5.7% | +2.7% | +0.6% | -9.5% | +8.2% | +4.5% | -2.4% | -12.3% | +11.1% |
| YoY Change | — | — | — | — | +2.2% | +4.5% | +16.2% | +2.5% | +0.8% | -6.2% | -18.2% | -3.9% | +0.0% | +0.6% | -1.2% | +1.1% | +2.8% | -0.2% | -3.3% | -0.6% |
Range$3.15B – $4.03B
CAGR+0.2%
Avg YoY Growth-0.2%
Median YoY Growth+0.3%
Other accrued liabilities at Other Companies
Frequently Asked Questions
- What is Medtronic's other accrued liabilities?
- Medtronic (MDT) reported other accrued liabilities of $3.50B in Q4 2025.
- How has Medtronic's other accrued liabilities changed year-over-year?
- Medtronic's other accrued liabilities decreased by 0.6% year-over-year, from $3.53B to $3.50B.
- What is the long-term trend for Medtronic's other accrued liabilities?
- Over 4 years (2021 to 2025), Medtronic's other accrued liabilities has grown at a 1.5% compound annual growth rate (CAGR), from $3.48B to $3.68B.
- What does other accrued liabilities mean?
- Miscellaneous short-term debts or obligations not covered by other standard categories.